Published: 11/28/2025 9:01:38 AM

Synthetic MR Q3: Impairment of contract assets - SEB

Q3 showed sales decreasing 7% y/y, leading to a miss of 9% vs. SEB expectations. Reported EBIT was SEK -25m (SEB at -4m), impacted by an -18m impairment of contract assets. FCF was SEK -5m and current cash position 13m. Our first take is for 2026 sales estimates to come down by high single-digits. Although cash collection has improved, the impairment suggests the historical sales cannot be fully relied on as an indicator of the historical demand level.

Link to the analysis

Read more about SyntheticMR AB